Remus Pharmaceuticals Ltd share price logo

Remus Pharmaceuticals Ltd Share Price (REMUS)

Check the latest share price of Remus Pharmaceuticals Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹1914.10.82%

as on 04:01PM, 13 Jun 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Remus Pharmaceuticals Ltd Stock Performance

Get live Remus Pharmaceuticals Ltd share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹1,887
    Day's Price Range
    ₹1,930
  • 52 Week's Low

    52 Week's High

    ₹1,200
    52-Week Price Range
    ₹2,834.75
1 Month Return-11.14 %
3 Month Return-4.04 %
1 Year Return-7.98 %
3 Year Return+ 326.11 %
5 Year Return+ 326.11 %
Previous Close₹1,930.00
Open₹1,915.00
Volume2,900.00
Upper Circuit₹2,316.00
Lower Circuit₹1,544.00

Remus Pharmaceuticals Ltd Fundamentals & Key Indicators

Check Remus Pharmaceuticals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹6.24 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

0

Return on capital employed (ROCE)

0

Beta (LTM)

0.32

P/B Ratio

-0.04

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

0

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

How to invest in Remus Pharmaceuticals Ltd?

Investing in Remus Pharmaceuticals Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Remus Pharmaceuticals Ltd or REMUS on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Remus Pharmaceuticals Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Remus Pharmaceuticals Ltd with just a few clicks!

Remus Pharmaceuticals Ltd Stock's Interest Amongst Investors

267%

Period Jun 14, 2025 to May 15, 2025. Change in 30 Days vs previous period

Search interest for Remus Pharmaceuticals Ltd Stock has increased by 267% in the last 30 days, reflecting an upward trend in search activity.

Remus Pharmaceuticals Ltd Financial Results

Get the annual and quarterly financial summary of Remus Pharmaceuticals Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

11 (0%)16 (44%)35 (119%)98 (183%)
Total Liabilities

(in ₹ Cr)

8 (0%)9 (18%)16 (67%)16 (3%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

1 (0%)-0 (109%)5 (4300%)5 (5%)2 (54%)

Remus Pharmaceuticals Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Remus Pharmaceuticals Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
70.85%
0.00
Foreign Institutions
4.77%
0.00
Mutual Funds
0%
0.00
Retail Investors
23.6%
0.00
Others
0.77%
0.00

Remus Pharmaceuticals Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Remus Pharmaceuticals Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA6.245.19%5.69NANA
NA81.5858.65%0.51140
NA1,949.0625.81%0.5158630
NA69.916.88%0.78245
NA375.2830.71%0.51NANA

Insights on Remus Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 70.84% to 70.85% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 3.16% to 4.77% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 25.22% to 23.60% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, REMUS stock has moved down by -11.1%

About Remus Pharmaceuticals Ltd

Remus Pharmaceuticals Limited, originally incorporated as Remus Pharmaceuticals Private Limited in 2015, is engaged in the marketing and distribution of finished formulations of pharmaceutical drugs. It deals in various drug forms such as capsules, creams, gel, injection, tablets, etc. and supplies therapeutic drugs like ACE inhibitors, anaesthetics, antihistamines, anticancer, etc. Remus Pharmaceuticals' core business includes manufacturing approved finished formulations through loan licence and contract manufacturing, trading of Active Pharmaceutical Ingredients and Technical Consultancy on preparation of reports on pharmaceutical dossiers. It has a product portfolio of 429 products, 58 domestic distributors and 139 international distributors. Currently, the company is proposing an initial public offering of up to 388000 Equity Shares through its Fresh Issue.

Listing date: 29 May, 2023
OrganisationRemus Pharmaceuticals Ltd
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Remus Pharmaceuticals Ltd share price today?

Remus Pharmaceuticals Ltd share price today stands at ₹1914.1, Open: ₹1915, Previous Close: ₹1930, High: ₹1930, Low: ₹1887, 52 Week High: ₹2834.75, 52 Week Low: ₹1200.

What is today's traded volume of Remus Pharmaceuticals Ltd?

Today's traded volume of Remus Pharmaceuticals Ltd is 2,900.00. Which means that 2,900.00 shares of Remus Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.

What is Remus Pharmaceuticals Ltd's market cap today?

Today's market capitalisation of Remus Pharmaceuticals Ltd is ₹1,127.79 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Remus Pharmaceuticals Ltd?

Remus Pharmaceuticals Ltd’s 52 week high is ₹2834.75 and 52 week low is ₹1200. The current share price of Remus Pharmaceuticals Ltd is ₹1914.1, which is -32.48% down from its 52 week high and 59.51% up from its 52 week low.